Zehua Wang Selected Research

olaparib

9/2021	Combination treatment with cisplatin, paclitaxel and olaparib has synergistic and dose reduction potential in ovarian cancer cells.
1/2020	Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib.
3/2019	Olaparib induced senescence under P16 or P53 dependent manner in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zehua Wang Research Topics

Disease

85	Neoplasms (Cancer) 10/2022 - 01/2002
41	Ovarian Neoplasms (Ovarian Cancer) 09/2021 - 01/2004
28	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2005
17	Ovarian Epithelial Carcinoma 01/2021 - 04/2003
11	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2005
9	Breast Neoplasms (Breast Cancer) 10/2020 - 01/2006
9	Carcinogenesis 10/2020 - 10/2010
5	Infections 01/2020 - 12/2002
4	Lymphatic Metastasis 10/2021 - 08/2011
4	Carcinoma (Carcinomatosis) 12/2020 - 03/2010
4	Prostatic Neoplasms (Prostate Cancer) 11/2016 - 02/2012
3	Uterine Cervical Dysplasia 01/2017 - 01/2005
2	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2017
2	Inflammation (Inflammations) 01/2022 - 01/2017
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2021
2	COVID-19 01/2021 - 01/2020
2	Pathologic Processes 01/2021 - 04/2013
2	Lung Neoplasms (Lung Cancer) 12/2020 - 02/2017
2	Hemorrhage 01/2020 - 09/2011
2	Disease Progression 02/2019 - 01/2014
2	Pre-Eclampsia (Preeclampsia) 04/2017 - 02/2004
2	Ascites 11/2015 - 01/2002
2	Endometrial Neoplasms (Endometrial Cancer) 06/2010 - 06/2008
1	Pain (Aches) 12/2021
1	Esophageal Neoplasms (Esophageal Cancer) 02/2021
1	Persistent Infection 01/2021

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2006
17	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 01/2004
13	PlatinumIBA 09/2021 - 07/2005
10	Pharmaceutical PreparationsIBA 09/2021 - 10/2010
10	Biomarkers (Surrogate Marker)IBA 10/2020 - 08/2013
10	Messenger RNA (mRNA)IBA 06/2019 - 02/2004
9	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2010
9	Paclitaxel (Taxol)FDA LinkGeneric 09/2021 - 07/2005
7	Biological ProductsIBA 10/2022 - 01/2002
7	Small Interfering RNA (siRNA)IBA 11/2021 - 01/2006
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2004
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2017 - 10/2009
5	Long Noncoding RNAIBA 01/2021 - 01/2018
5	Enhancer of Zeste Homolog 2 ProteinIBA 06/2018 - 04/2013
4	VimentinIBA 10/2021 - 08/2011
4	Cadherins (E-Cadherin)IBA 10/2021 - 12/2010
4	EnzymesIBA 11/2018 - 10/2009
4	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 06/2009
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2018
3	Lactic Acid (Lactate)FDA LinkGeneric 11/2021 - 11/2019
3	Indicators and Reagents (Reagents)IBA 10/2021 - 01/2005
3	olaparibIBA 09/2021 - 03/2019
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2006
3	HeterochromatinIBA 01/2021 - 03/2019
3	CytokinesIBA 01/2020 - 12/2002
3	AngiopoietinsIBA 01/2020 - 01/2017
3	Voltage-Gated Sodium ChannelsIBA 02/2019 - 02/2009
3	Conditioned Culture MediaIBA 12/2017 - 11/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 01/2020
2	Epidermal Growth Factor (EGF)IBA 01/2022 - 01/2020
2	Angiopoietin-2IBA 01/2022 - 01/2017
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2021 - 03/2019
2	Therapeutic UsesIBA 02/2021 - 12/2020
2	Estrogen ReceptorsIBA 10/2020 - 09/2013
2	TOR Serine-Threonine KinasesIBA 10/2020 - 06/2008
2	Histones (Histone)IBA 01/2020 - 10/2010
2	ImmunosorbentsIBA 01/2017 - 10/2009
2	Androgen Receptors (Androgen Receptor)IBA 11/2016 - 02/2012
2	Lysine (L-Lysine)FDA Link 11/2016 - 10/2010
2	MethyltransferasesIBA 01/2016 - 10/2010
2	Carboplatin (JM8)FDA LinkGeneric 01/2015 - 03/2012
2	CateninsIBA 04/2014 - 08/2011
2	Histone MethyltransferasesIBA 03/2014 - 01/2014
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 09/2013 - 01/2013
2	UbiquitinIBA 09/2013 - 01/2013
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2012 - 10/2010
2	CXCR4 Receptors (CXCR4 Receptor)IBA 08/2011 - 06/2009
2	CollagenIBA 06/2009 - 01/2006
2	Caspase 3 (Caspase-3)IBA 01/2006 - 01/2005
2	SurvivinIBA 07/2005 - 01/2005
2	cloricromen (AD 6)IBA 03/2005 - 01/2004
1	LigandsIBA 01/2022
1	Dexmedetomidine FDA Link 12/2021
1	Sincalide FDA Link 11/2021
1	Fluorouracil (Carac)FDA LinkGeneric 11/2021
1	Antineoplastic Agents (Antineoplastics)IBA 09/2021
1	CRISPR-Associated Protein 9IBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	NAD (NADH)IBA 01/2021
1	OxysterolsIBA 01/2021

Therapy/Procedure

20	Drug Therapy (Chemotherapy) 09/2021 - 04/2003
14	Therapeutics 01/2022 - 02/2012
10	Hysterectomy 01/2022 - 06/2010
8	Lymph Node Excision (Lymph Node Dissection) 10/2021 - 04/2003
5	Neoadjuvant Therapy 01/2020 - 07/2012
3	Radiotherapy 10/2021 - 03/2012
2	Immunotherapy 01/2022 - 01/2021
2	Aftercare (After-Treatment) 03/2012 - 01/2006
1	Adjuvant Chemotherapy 01/2022
1	Gastrectomy 01/2022
1	Minimally Invasive Surgical Procedures 01/2022
1	Radiofrequency Ablation 01/2022
1	Cytoreduction Surgical Procedures 09/2021
1	Drug Tapering 09/2021